Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Double-blind, Randomized, Comparator-controlled Study of the Safety and Efficacy of Zoenasa™ Rectal Gel (Mesalamine Plus N-acetylcysteine) in Subjects With Left-sided Ulcerative Colitis

NCT01586533 is registered in ClinicalTrials.gov with Altheus Therapeutics, Inc. as lead sponsor.

NCT NCT01586533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01586533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Double-blind, Randomized, Comparator-controlled Study of the Safety and Efficacy of Zoenasa™ Rectal Gel (Mesalamine Plus N-acetylcysteine) in Subjects With Left-sided Ulcerative Colitis
Lead sponsor
Altheus Therapeutics, Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2012
Completion date
Not reported
Enrollment
120 (estimated)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

distal ulcerative colitis, left-sided ulcerative colitis, ulcerative colitis